US EditionOusted FDA Vaccine Regulator Vinay Prasad Returns to Post
MONTGOMERY COUNTY, MARYLAND, AUG 11 – Vinay Prasad returns to lead the FDA's biologics center amid controversy over gene therapy regulation and political pressure linked to patient safety concerns.
- Vinay Prasad has resumed leadership of the FDA division responsible for regulating biologics, returning less than two weeks after stepping down at the agency's request.
- Prasad's removal on July 29 followed criticism from conservative figures, including Laura Loomer, who opposed his regulatory decisions and past political views.
- Prasad’s tenure occurred amid intense scrutiny over FDA's regulation of gene therapies, highlighted by safety concerns linked to Sarepta Therapeutics’ product and related deaths.
- HHS spokesperson Andrew Nixon confirmed Prasad’s return was at the FDA's request, while Loomer called the decision an 'egregious personnel decision' and vowed to investigate further.
- Prasad’s reinstatement signals leadership continuity at a time of scientific, regulatory, and political pressures on the FDA’s biologics sector amid ongoing agency restructuring.
Insights by Ground AI
Does this summary seem wrong?
14 Articles
14 Articles
Dr. Vinay Prasad returns to FDA vindicated
By LINDA BOYLE Dr. Vinay Prasad, a nationally known hematologist-oncologist, took the helm of the FDA’s powerful Center for Biologics Evaluation and Research in early May. It was a position with vast influence over vaccines and other biologics. Just two months later, he abruptly resigned amid a coordinated smear campaign involving Big Pharma, right-wing firebrand […] The post Dr. Vinay Prasad returns to FDA vindicated appeared first on Must Read…
US Drug Regulator's Ousted Vaccine Chief Vinay Prasad Is Returning To Agency
A Food and Drug Administration official is getting his job back as the agency's top vaccine regulator, less than two weeks after he was pressured to step down at the urging of biotech executives, patient groups and conservative allies of Trump.
·New Delhi, India
Read Full Article
Coverage Details
Total News Sources14
Leaning Left3Leaning Right2Center5Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 30%
C 50%
R 20%
Factuality
To view factuality data please Upgrade to Premium
